Clinical Trials Browser

Phase 2 × Moxifloxacin × Tumor-Agnostic × Clear all

NCT01017731 2015-06-10

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Phase 2 Completed

68 enrolled 13 charts

Neoplasm Metastasis, Neoplasms